[
    {
        "data": {
            "description": "Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.",
            "id": "PHMSCI 762",
            "parent": "PHMSCI",
            "title": "THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)"
        }
    },
    {
        "data": {
            "id": "PHMSCI",
            "type": "compound"
        }
    }
]